Second Phase Of Takeda’s Globalization Plan Calls For Partial Integration Of Millennium
This article was originally published in PharmAsia News
Executive Summary
The next phase of Takeda’s globalization strategy emphasizes organizational house cleaning. Millennium, which had operated as a standalone oncology outpost, will be partially integrated into Takeda R&D but the commitment to oncology in terms of resources and investment remains firm.